Scott D. Wilkin
Analyst-Equity chez UBS Asset Management (UK) Ltd.
Profil
Scott D.
Wilkin is currently the Head of Global Equity at UBS Asset Management (UK) Ltd.
He previously worked as the Director of Research & Portfolio Manager at UBS Asset Management (Americas) LLC from 2012 to 2016.
Prior to that, he was a Managing Director at Cowen & Co. LLC and SG Cowen Securities Corp.
He also served as the Manager of Business Development at Dura Pharmaceuticals, Inc. from 1995 to 1997 and as an Analyst at Warburg Dillon Read LLC from 1997 to 1999.
Additionally, he worked as a Market Research Consultant at Boston Biomedical Consultants, Inc. Mr. Wilkin obtained his undergraduate degree from Bowdoin College in 1990 and holds an MBA from Harvard Business School.
Postes actifs de Scott D. Wilkin
| Sociétés | Poste | Début |
|---|---|---|
UBS Asset Management (UK) Ltd.
 UBS Asset Management (UK) Ltd. Investment ManagersFinance UBS Asset Management (UK) Ltd. (UBS-UK) is the Great Britain-based investment subsidiary of UBS Asset Management Holdings Ltd., itself a subsidiary of UBS Group AG (SWX: UBSG, NYSE: UBS) in Switzerland. Founded in 1981 as Phillips & Drew Investment Management Ltd., the firm merged with UBS Asset Management in 2000 to form UBS Asset Management Ltd., which became UBS Global Asset Management (UK) Ltd. in 2002. They changed their name to UBS Asset Management (UK) Ltd. in 2015. Headquartered in London, UBS-UK provides asset management services to corporate and public pension plans, sovereign institutions, endowments and municipalities, charities, insurance companies, wholesale intermediaries, financial institutions, and private clients. | Analyst-Equity | 01/08/2016 |
Anciens postes connus de Scott D. Wilkin
| Sociétés | Poste | Fin |
|---|---|---|
| Warburg Dillon Read LLC | Analyst-Equity | - |
Dura Pharmaceuticals, Inc.
 Dura Pharmaceuticals, Inc. BiotechnologyHealth Technology Dura Pharmaceuticals, Inc. markets and sells prescription products that treat infectious and respiratory diseases. Dura focuses on products and transactions that leverage its sales and marketing organization. Dura also intends, through the use of collaborative relationships, to develop the Spiros® motorized blisterdisk and Spiros® S2 pulmonary drug delivery systems for the local and systemic delivery of a wide range of medications. It is located in San Diego, CA. | Corporate Officer/Principal | - |
Boston Biomedical Consultants, Inc.
 Boston Biomedical Consultants, Inc. Miscellaneous Commercial ServicesCommercial Services Boston Biomedical Consultants, Inc. provides consulting services to health industries. Its consulting services include market sizing and forecasting, IVD opportunity assessment, evaluation of emerging markets, merger/acquisition due diligence and evaluation of emerging technologies. The company was founded by Henry M. Weinert in 1977 and is headquartered in Waltham, MA. | Corporate Officer/Principal | - |
| SG Cowen Securities Corp. | Corporate Officer/Principal | - |
Cowen & Co. LLC
 Cowen & Co. LLC Investment Banks/BrokersFinance Cowen & Co. LLC is a SEC-registered broker/dealer headquartered in New York City. The firm was founded in 2004 and is a subsidiary of Cowen Holdings, Inc., ultimately owned by The Toronto-Dominion Bank (TSE: TD) in Canada. Cowen & Co. offers industry-focused investment banking for growth-oriented companies, domain knowledge-driven research and a sales and trading platform for institutional investors. Their institutional sales and trading business serves both equity and fixed-income clients. Sales and trading execution platform is structured around the following key verticals: (1) healthcare (2) technology, telecommunications and media (TMT) (3) REITs and financials (4) aerospace and defense (5) consumer and (6) alternative energy. | Corporate Officer/Principal | - |
Formation de Scott D. Wilkin
| Bowdoin College | Undergraduate Degree |
| Harvard Business School | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 7 |
|---|---|
UBS Asset Management (Americas), Inc.
 UBS Asset Management (Americas), Inc. Investment ManagersFinance UBS Asset Management (Americas) LLC (UBS AM) is a SEC-registered investment advisor headquartered in New York City. The firm was founded in 2000 as UBS Global Asset Management (Americas), Inc. They are a wholly owned subsidiary of UBS Americas, Inc., ultimately owned by UBS Group AG (SIX: UBSG; NYSE: UBS) in Switzerland. UBS AM provides investment products and services to corporate and public pension plans, financial institutions and advisors, central banks, charities, foundations and individual investors around the world. | Finance |
Cowen & Co. LLC
Cowen & Co. LLC Investment Banks/BrokersFinance Cowen & Co. LLC is a SEC-registered broker/dealer headquartered in New York City. The firm was founded in 2004 and is a subsidiary of Cowen Holdings, Inc., ultimately owned by The Toronto-Dominion Bank (TSE: TD) in Canada. Cowen & Co. offers industry-focused investment banking for growth-oriented companies, domain knowledge-driven research and a sales and trading platform for institutional investors. Their institutional sales and trading business serves both equity and fixed-income clients. Sales and trading execution platform is structured around the following key verticals: (1) healthcare (2) technology, telecommunications and media (TMT) (3) REITs and financials (4) aerospace and defense (5) consumer and (6) alternative energy. | Finance |
| Warburg Dillon Read LLC | Finance |
Dura Pharmaceuticals, Inc.
Dura Pharmaceuticals, Inc. BiotechnologyHealth Technology Dura Pharmaceuticals, Inc. markets and sells prescription products that treat infectious and respiratory diseases. Dura focuses on products and transactions that leverage its sales and marketing organization. Dura also intends, through the use of collaborative relationships, to develop the Spiros® motorized blisterdisk and Spiros® S2 pulmonary drug delivery systems for the local and systemic delivery of a wide range of medications. It is located in San Diego, CA. | Health Technology |
| SG Cowen Securities Corp. | Finance |
Boston Biomedical Consultants, Inc.
Boston Biomedical Consultants, Inc. Miscellaneous Commercial ServicesCommercial Services Boston Biomedical Consultants, Inc. provides consulting services to health industries. Its consulting services include market sizing and forecasting, IVD opportunity assessment, evaluation of emerging markets, merger/acquisition due diligence and evaluation of emerging technologies. The company was founded by Henry M. Weinert in 1977 and is headquartered in Waltham, MA. | Commercial Services |
UBS Asset Management (UK) Ltd.
UBS Asset Management (UK) Ltd. Investment ManagersFinance UBS Asset Management (UK) Ltd. (UBS-UK) is the Great Britain-based investment subsidiary of UBS Asset Management Holdings Ltd., itself a subsidiary of UBS Group AG (SWX: UBSG, NYSE: UBS) in Switzerland. Founded in 1981 as Phillips & Drew Investment Management Ltd., the firm merged with UBS Asset Management in 2000 to form UBS Asset Management Ltd., which became UBS Global Asset Management (UK) Ltd. in 2002. They changed their name to UBS Asset Management (UK) Ltd. in 2015. Headquartered in London, UBS-UK provides asset management services to corporate and public pension plans, sovereign institutions, endowments and municipalities, charities, insurance companies, wholesale intermediaries, financial institutions, and private clients. | Finance |
